Tempus recently announced a new collaboration with Median Technologies. This partnership integrates advanced AI lung cancer screening into the Tempus Pixel platform. The collaboration focuses on Median’s eyonis® LCS software. This tool helps clinicians identify lung nodules with higher accuracy.
The Pixel platform acts as a central hub for medical data. Now, it will include specialized imaging AI for oncology. This update aims to simplify the screening process for health systems. Early detection is critical for improving patient survival rates.
Enhancing Precision Oncology Workflows
The eyonis® software recently received FDA 510(k) clearance. It uses deep learning to analyze chest scans with 93.3% sensitivity. It assists radiologists in finding early-stage cancers that are easily missed. Furthermore, the system provides a proprietary nodule malignancy score. This technology helps clinical teams stratify and prioritize high-risk patients.
The companies want to make high-quality screening more accessible. They aim to reduce the time between screening and treatment. Consequently, patients receive care much faster than before. This partnership marks a major step in precision medicine.
“Activating our distribution collaboration with Tempus AI is a decisive step in bringing eyonis® LCS to patients at a national scale,” said Fredrik Brag, CEO and Founder of Median Technologies.
“We believe AI reaches its full potential when it helps clinicians identify disease earlier and more accurately,” said Razik Yousfi, Tempus SVP and GM of AI Products.“By expanding our Pixel platform, we are enabling radiologists to manage complex caseloads.”
In conclusion, this collaboration strengthens the fight against cancer. It combines genomic data with advanced imaging technology. The use of AI lung cancer screening will likely become a clinical standard. Tempus continues to lead innovation in the digital health space.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
